Table 1.
nasal lavage fluids | nasal tissue extracts | ||||||
---|---|---|---|---|---|---|---|
Control | CRSsNP | CRSwNP | Control | CRSsNP | CRSwNP | ||
(n=15) | (n=15) | (n=21) | UT (n=8) | UT (n=7) | UT (n=7) | NP (n=15) | |
Gender, male/female | 6/9 | 4/11 | 14/7* | 1/7 | 5/2 | 5/2 | 13/2* |
Ethnicity, White/non-White/unknown | 6/4/5 | 13/1/1* | 14/5/2 | 7/0/1 | 6/1/0 | 5/2/0 | 8/5/2 |
Age, years | 36.1±10.4 | 45.2±15.4 | 47.8±13.0** | 58.1±9.4 | 36.3±12.9* | 43.4±13.0* | 49.1±11.2# |
Comorbidity, yes/no/unknown | |||||||
Asthma | 0/15/0 | 6/9/0 | 9/12/0 | 1/7/0 | 3/4/0 | 4/3/0 | 6/9/0 |
Atopy | 4/6/5 | 6/8/1 | 11/9/1 | 3/0/5 | 4/3/0 | 4/1/2 | 12/1/2 |
Steroid use, yes/no | |||||||
Oral | 0/15 | 0/15 | 3/18 | 1/7 | 1/6 | 2/5 | 2/13 |
Inhaled | 0/15 | 2/13 | 3/18 | 0/8 | 1/6 | 2/5 | 1/14 |
Intranasal | 2/13 | 2/13 | 2/19 | 0/8 | 2/5 | 2/5 | 4/11 |
p<0.05, vs. Control
p<0.01, vs. Control
p<0.05, vs. CRSsNP